Moreover, c-MET has been found to be upregulated and in an activated state upon hypoxic conditions mediated by VEGFR inhibitors and pericyte loss in breast cancer models, including the 4T1 fat pad model48. The gene discussed is MET; the disease is breast carcinoma.